Literature DB >> 19570823

Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.

Jin Wang1, Yannan Ouyang, Yigit Guner, Henri R Ford, Anatoly V Grishin.   

Abstract

Although enterocytes are capable of innate immune responses, the intestinal epithelium is normally tolerant to commensal bacteria. To elucidate the mechanisms of tolerance, we examined the effect of preexposure to LPS on activation of p38, c-Jun, and NF-kappaB in enterocytes by several inflammatory and stress stimuli. Shortly after the initial LPS challenge, enterocytes become tolerant to restimulation with LPS or CpG DNA, but not with IL-17 or UV. The state of tolerance, which lasts 20-26 h, temporally coincides with LPS-induced expression of the anti-inflammatory ubiquitin-editing enzyme A20. Small interfering RNA silencing of A20 prevents tolerance, whereas ectopic expression of A20 blocks responses to LPS and CpG DNA, but not to IL-17 or UV. A20 levels in the epithelium of the small intestine are low at birth and following gut decontamination with antibiotics, but high under conditions of bacterial colonization. In the small intestine of adult rodents, A20 prominently localizes to the luminal interface of villus enterocytes. Lower parts of the crypts display relatively low levels of A20, but relatively high levels of phospho-p38. Gut decontamination with antibiotics reduces the levels of both A20 and phospho-p38. Along with the fact that A20-deficient mice develop severe intestinal inflammation, our results indicate that induction of A20 plays a key role in the tolerance of the intestinal epithelium to TLR ligands and bacteria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570823      PMCID: PMC2739219          DOI: 10.4049/jimmunol.0803987

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Engineering mucosal RNA interference in vivo.

Authors:  Yingjie Zhang; Patricia Cristofaro; Rebecca Silbermann; Oliver Pusch; Daniel Boden; Tamako Konkin; Virginia Hovanesian; Paul R Monfils; Murray Resnick; Steven F Moss; Bharat Ramratnam
Journal:  Mol Ther       Date:  2006-06-12       Impact factor: 11.454

2.  A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha.

Authors:  M Funakoshi; K Tago; Y Sonoda; S Tominaga ; T Kasahara
Journal:  Biochem Biophys Res Commun       Date:  2001-04-27       Impact factor: 3.575

Review 3.  TLR4 signalling in the intestine in health and disease.

Authors:  M Fukata; M T Abreu
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

Review 4.  Innate immunity in inflammatory bowel disease.

Authors:  Jesus-K Yamamoto-Furusho; Daniel-K Podolsky
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

5.  Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance.

Authors:  Elke Cario; Douglas T Golenbock; Alberto Visintin; Michael Rünzi; Guido Gerken; Daniel K Podolsky
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

6.  Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.

Authors:  Betty Lamothe; Arnaud Besse; Alejandro D Campos; William K Webster; Hao Wu; Bryant G Darnay
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

7.  The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.

Authors:  Osamu Hitotsumatsu; Regina-Celeste Ahmad; Rita Tavares; Min Wang; Dana Philpott; Emre E Turer; Bettina L Lee; Nataliya Shiffin; Rommel Advincula; Barbara A Malynn; Catherine Werts; Averil Ma
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

8.  IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines.

Authors:  Dirk Haller; Maria P Russo; R Balfour Sartor; Christian Jobin
Journal:  J Biol Chem       Date:  2002-07-24       Impact factor: 5.157

9.  MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells.

Authors:  Christelle Lenoir; Catherine Sapin; Alexis H Broquet; Anne-Marie Jouniaux; Sabine Bardin; Isabelle Gasnereau; Ginette Thomas; Philippe Seksik; Germain Trugnan; Joëlle Masliah; Maria Bachelet
Journal:  Life Sci       Date:  2007-12-17       Impact factor: 5.037

10.  Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling.

Authors:  Noula Shembade; Nicole S Harhaj; Daniel J Liebl; Edward W Harhaj
Journal:  EMBO J       Date:  2007-08-16       Impact factor: 11.598

View more
  34 in total

Review 1.  Enterocytes: active cells in tolerance to food and microbial antigens in the gut.

Authors:  N Miron; V Cristea
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.

Authors:  Michael B Murphy; Yanbao Xiong; Goutham Pattabiraman; Tissa T Manavalan; Fu Qiu; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2015-08-26       Impact factor: 4.962

3.  Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis.

Authors:  Lesley Rhee; Stephen F Murphy; Lauren E Kolodziej; Wesley A Grimm; Christopher R Weber; James P Lodolce; Jonathan E Chang; Sarah J Bartulis; Jeannette S Messer; Jeff R Schneider; Shirley Paski; Thomas M Nero; David L Boone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-17       Impact factor: 4.052

4.  IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.

Authors:  Yanbao Xiong; Meghan Pennini; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2013-05-21       Impact factor: 4.962

5.  Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.

Authors:  Romina Fiorotto; Roberto Scirpo; Michael Trauner; Luca Fabris; Rafaz Hoque; Carlo Spirli; Mario Strazzabosco
Journal:  Gastroenterology       Date:  2011-06-26       Impact factor: 22.682

6.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

Review 7.  Dendritic cell-based vaccines: barriers and opportunities.

Authors:  Jessica A Cintolo; Jashodeep Datta; Sarah J Mathew; Brian J Czerniecki
Journal:  Future Oncol       Date:  2012-10       Impact factor: 3.404

8.  Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

Authors:  Jin Wang; Anatoly V Grishin; Henri R Ford
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

9.  Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.

Authors:  Lars Vereecke; Mozes Sze; Conor Mc Guire; Brecht Rogiers; Yuanyuan Chu; Marc Schmidt-Supprian; Manolis Pasparakis; Rudi Beyaert; Geert van Loo
Journal:  J Exp Med       Date:  2010-06-07       Impact factor: 14.307

10.  Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.

Authors:  Xiaofei Gao; Fengyi Wan; Kristina Mateo; Eduardo Callegari; Dan Wang; Wanyin Deng; Jose Puente; Feng Li; Michael S Chaussee; B Brett Finlay; Michael J Lenardo; Philip R Hardwidge
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.